Conditions: Submental Fat Healthy
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 205
Healthy volunteers: yes

Brief summary:
This was a long-term follow-up study of participants who completed Kythera-sponsored trials of ATX-101 (06-03, 07-07, 09-15)

Detailed description:
No study medication was administered in this study.

Arms:
arm 1: Participants treated with placebo in previous ATX-101 studies arm 2: Participants treated with ATX-101 (1 mg/cm\^2) in previous phase 2 studies arm 3: Participants treated with ATX-101 (2 mg/cm\^2) in previous phase 2 studies arm 4: Participants treated with ATX-101 (4 mg/cm\^2) in previous phase 2 studies

Interventions: intervention 1: Placebo intervention 2: ATX-101 (1 mg/cm^2) intervention 3: ATX-101 (2 mg/cm^2) intervention 4: ATX-101 (4 mg/cm^2)
Intervention descriptions: intervention 1: Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events intervention 2: Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events intervention 3: Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events intervention 4: Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events

Protocol document: